Authors:
PESTELL KE
MEDLOW CJ
JONES M
VALENTI M
BRUNTON L
KELLAND LR
WALTON MI
Citation: Ke. Pestell et al., ROLE OF P53 IN HUMAN OVARIAN-CANCER TUMOR XENOGRAFTS CURABLE WITH CISPLATIN, British Journal of Cancer, 78, 1998, pp. 14-14
Authors:
JACKMAN AL
KIMBELL R
AHERNE GW
BRUNTON L
JANSEN G
STEPHENS TC
SMITH MN
WARDLEWORTH JM
BOYLE FT
Citation: Al. Jackman et al., CELLULAR PHARMACOLOGY AND IN-VIVO ACTIVITY OF A NEW ANTICANCER AGENT,ZD9331 - A WATER-SOLUBLE, NONPOLYGLUTAMATABLE, QUINAZOLINE-BASED INHIBITOR OF THYMIDYLATE SYNTHASE, Clinical cancer research, 3(6), 1997, pp. 911-921
Authors:
JACKMAN AL
KIMBELL R
BROWN M
BRUNTON L
BOYLE FT
Citation: Al. Jackman et al., QUINAZOLINE THYMIDYLATE SYNTHASE INHIBITORS - METHODS FOR ASSESSING THE CONTRIBUTION OF POLYGLUTAMATION TO THEIR IN-VITRO ACTIVITY, Anti-cancer drug design, 10(7), 1995, pp. 555-572
Authors:
JACKMAN AL
KIMBELL R
BROWN M
BRUNTON L
BISSET GMF
BAVETSIAS V
MARSHAM P
HUGHES LR
BOYLE FT
Citation: Al. Jackman et al., QUINAZOLINE-BASED THYMIDYLATE SYNTHASE INHIBITORS - RELATIONSHIP BETWEEN STRUCTURAL MODIFICATIONS AND POLYGLUTAMATION, Anti-cancer drug design, 10(7), 1995, pp. 573-589